If we are to bring the global threat of AMR under control, we must ensure that new antibiotics currently in development make it to the people who need them most, this plan makes a strong argument for continuing UK leadership on this important debate, but we must move further and faster to ensure there is a sustainable pipeline for the antibiotics we so urgently need.